Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0002736 (
amyotrophic lateral sclerosis
)
19,048
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Recent findings implicating
TRPM7
and TRPM2 in oxidative stress-induced neuronal death thrust these channels into the spotlight as possible therapeutic targets for neurodegenerative diseases. In this review, we describe how the functional properties of
TRPM7
and TRPM2 are interconnected with calcium (Ca(2+)) and magnesium (Mg(2+)) homeostasis, oxidative stress, mitochondrial dysfunction, and immune mechanisms, all principal suspects in neurodegeneration. We focus our discussion on Western Pacific
Amyotrophic Lateral Sclerosis
(
ALS
) and Parkinsonism Dementia (PD) because extensive studies conducted over the years strongly suggest that these diseases are ideal candidates for a gene-environment model of etiology. The unique mineral environment identified in connection with Western Pacific
ALS
and PD, low Mg(2+) and Ca(2+), yet high in transition metals, creates a condition that could affect the proper function of these two channels.
...
PMID:TRPM7 and TRPM2-Candidate susceptibility genes for Western Pacific ALS and PD? 1739 33
Amyotrophic lateral sclerosis
-parkinsonism dementia complex (
ALS
/PDC) is a distinct neurodegenerative disorder characterized by
ALS
pathology with neurofibrillary tangles (NFTs) in the spinal cord and brain. Recent clinical studies have revealed a high incidence and a high familial occurrence of
ALS
/PDC in both Guam and the Kii peninsula of Japan, suggesting a strong genetic predisposition to this disorder. The T1482I variant (rs8042919) of
TRPM7
gene which is suggested to play roles in regulating the cellular homeostasis of Ca(2+), Mg(2+), and trace metals, has recently been reported to be associated with Guamanian patients with
ALS
/PDC. To investigate whether
TRPM7
is associated with Kii
ALS
/PDC, we conducted parametric linkage analyses of the
TRPM7
locus in a large extended family with
ALS
/PDC. Linkage analysis did not reveal any evidence supporting the linkage to the
TRPM7
locus. Resequencing of the entire coding region of
TRPM7
did not reveal any pathogenic mutations in an affected individual in this family. The allele frequencies of the T1482I in affected individuals in this family or in those from other families are not significantly different from those in regional controls or those in HapMap-JPT samples. These results indicate that
TRPM7
is not associated with
ALS
/PDC in the Kii peninsula of Japan.
...
PMID:TRPM7 is not associated with amyotrophic lateral sclerosis-parkinsonism dementia complex in the Kii peninsula of Japan. 1940 49
TRPM7
is a ubiquitously expressed nonselective cation channel fused to a C-terminal alpha kinase.
TRPM7
current is typically small at physiological magnesium concentrations, but large outwardly rectifying currents develop in low-magnesium extracellular solution when cells are dialyzed with magnesium free solutions during whole-cell patch clamp recordings. In addition to regulation by magnesium,
TRPM7
current is potentiated by low extracellular pH and inhibited by depletion of phosphatidylinositol 4,5-bisphosphate (PIP(2)) during phospholipase C mediated signaling events. A diverse body of literature has implicated
TRPM7
in fundamental cellular processes including death, survival, proliferation, cell cycle progression, magnesium homeostasis and responses to shear stress and oxidative stress. Global deletion of
TRPM7
in mouse results in embryonic lethality and a thymocyte-restricted conditional knockout exhibits defective thymopoeisis, suggesting a role for
TRPM7
in development and organogenesis. In disease states,
TRPM7
has been linked to Guamanian
amyotrophic lateral sclerosis
and parkinsonian dementia (
ALS
/PD), various forms of neoplasia, hypertension and delayed neuronal death following cerebral ischemia.
...
PMID:TRPM7, the Mg(2+) inhibited channel and kinase. 2129 Feb 95
The frequency of
amyotrophic lateral sclerosis
(
ALS
) mutations has been extensively investigated in several populations; however, a systematic analysis in Turkish cases has not been reported so far. In this study, we screened 477
ALS
patients for mutations, including 116 familial
ALS
patients from 82 families and 361 sporadic
ALS
(sALS) cases. Patients were genotyped for C9orf72 (18.3%), SOD1 (12.2%), FUS (5%), TARDBP (3.7%), and UBQLN2 (2.4%) gene mutations, which together account for approximately 40% of familial
ALS
in Turkey. No SOD1 mutations were detected in sALS patients; however, C9orf72 (3.1%) and UBQLN2 (0.6%) explained 3.7% of sALS in the population. Exome sequencing revealed mutations in OPTN, SPG11, DJ1, PLEKHG5, SYNE1,
TRPM7
, and SQSTM1 genes, many of them novel. The spectrum of mutations reflect both the distinct genetic background and the heterogeneous nature of the Turkish
ALS
population.
...
PMID:The distinct genetic pattern of ALS in Turkey and novel mutations. 2568 89
Parkinson's disease (PD) is a neurodegenerative disorder of the central nervous system with a clinically heterogeneous presentation that includes progressive loss of dopaminergic (DA) neurons in the substantia nigra. A minority of PD cases are familial and are caused by mutations in single genes. Most cases, however, are idiopathic PD, a complex multifactorial disorder with environmental and genetic contributors to etiology. Here, we first briefly summarize published evidence that among environmental contributors is dietary deficiency of magnesium. We then review genetic data suggesting that mutations in genes encoding two proteins contributing to cellular magnesium homeostasis confer risk for PD or other Parkinsonian conditions. First, the gene encoding magnesium transporter SLC41A1 is, among others, a candidate for the causative gene in the PARK16 locus where variation is associated with risk for idiopathic Parkinsonian disease. Studies of the function of SLC41A1 in animal models are needed to test whether this protein has a role in maintenance of dopaminergic neurons. Second, in a small study, a hypomorphic variant of
TRPM7
, a magnesium-permeable channel, was over-represented in cases of
amyotrophic lateral sclerosis
/ Parkinson dementia complex versus controls from the same ethnic group. Although this association was not detected in a second study, in zebrafish Trpm7 is necessary for terminal differentiation and reduction of toxin-sensitivity in dopaminergic neurons. Overall, epidemiological results support the possibility that mutations in genes relevant to magnesium homeostasis would alter PD risk, but deeper genetic analyses of PD patients are necessary to confirm whether
SLC41A1
and
TRPM7
are among such genes.
...
PMID:SLC41A1 and TRPM7 in magnesium homeostasis and genetic risk for Parkinson's disease. 3118 92